abrdn plc Purchases 40,525 Shares of Quanterix Co. (NASDAQ:QTRX)

abrdn plc raised its position in shares of Quanterix Co. (NASDAQ:QTRX - Free Report) by 24.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 206,923 shares of the company's stock after purchasing an additional 40,525 shares during the quarter. abrdn plc owned 0.54% of Quanterix worth $2,200,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the company. Emerald Mutual Fund Advisers Trust lifted its holdings in shares of Quanterix by 0.8% in the third quarter. Emerald Mutual Fund Advisers Trust now owns 563,247 shares of the company's stock worth $7,300,000 after buying an additional 4,406 shares in the last quarter. nVerses Capital LLC purchased a new position in shares of Quanterix in the third quarter worth $60,000. Janney Capital Management LLC lifted its holdings in shares of Quanterix by 33.6% in the third quarter. Janney Capital Management LLC now owns 23,553 shares of the company's stock worth $305,000 after buying an additional 5,930 shares in the last quarter. Peapack Gladstone Financial Corp purchased a new position in shares of Quanterix in the third quarter worth $131,000. Finally, SG Americas Securities LLC purchased a new position in shares of Quanterix in the third quarter worth $139,000. Hedge funds and other institutional investors own 86.48% of the company's stock.

Quanterix Stock Down 0.1 %

Quanterix stock traded down $0.01 during mid-day trading on Friday, reaching $8.05. 618,129 shares of the company's stock traded hands, compared to its average volume of 877,231. The company has a market cap of $310.12 million, a price-to-earnings ratio of -7.59 and a beta of 1.33. The stock has a 50 day moving average of $9.96 and a two-hundred day moving average of $11.78. Quanterix Co. has a 12-month low of $7.49 and a 12-month high of $29.70.

Quanterix (NASDAQ:QTRX - Get Free Report) last released its quarterly earnings results on Monday, December 23rd. The company reported ($0.22) earnings per share (EPS) for the quarter. Quanterix had a negative net margin of 30.12% and a negative return on equity of 11.74%. As a group, sell-side analysts forecast that Quanterix Co. will post -0.98 earnings per share for the current year.

Analysts Set New Price Targets

Separately, TD Cowen boosted their target price on shares of Quanterix from $13.50 to $16.00 and gave the stock a "hold" rating in a report on Wednesday, November 13th.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.